Skip to content

US · ITOC · MEDICAL - SPECIALTIES

iTonic Holdings Ltd. (ITOC) intrinsic value and stock valuation

$1.59as of 2026-11-21 · Mkt cap 2.72M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

iTonic Holdings Ltd. DCF and intrinsic value

InvestorsCraft values ITOC with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from ITOC’s statements →

iTonic Holdings Ltd. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Specialties Beijing, BE 100101 ftzy.com.cn

How the business is doing

Fiscal 2021–2025, USD

Revenue
$520K
20212025
Net income
-$-5.1M
20212025
Free cash flow
-$-3.24M
20212025
Total equity
$8.13M
20212025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$520K$450K$630K$680K$700K
Operating income-$-5.19M-$-770K-$-310K$30K$140K
Net income-$-5.1M-$-660K-$-240K$80K$190K
EPSd-$-317.96K-$-51.89K-$-16.55K$5.52K$13.1K
Operating cash flow-$-3.24M-$-780K-$-60K-$-120K$80K
Capital expenditure-$0.00-$0.00-$0.00$0.00$0.00
Free cash flow-$-3.24M-$-780K-$-60K-$-120K$80K
Total assets$9.1M$6.72M$1.62M$1.4M$1.33M
Total debt$140K$250K$160K$220K$300K
Net debt-$-1.35M-$-5.91M-$-70K$150K$160K
Total equity$8.13M$6.18M$310K$560K$950K
Cash and short-term investments$2.93M$6.16M$230K$70K$140K
Income statement
20252024202320222021
Revenue$520K$450K$630K$680K$700K
Cost of revenue$200K$100K$160K$120K$110K
Gross profit$330K$340K$470K$560K$590K
Research and development expenses$460K$90K$80K$70K$80K
Selling, general and administrative expenses$5.06M$1.02M$690K$460K$370K
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$5.51M$1.12M$780K$530K$450K
Cost and expenses$5.71M$1.22M$940K$650K$560K
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$10K$70K$60K$50K$70K
Ebitda-$-5.17M-$-570K-$-200K$130K$270K
Operating income-$-5.19M-$-770K-$-310K$30K$140K
Total other income/expenses, net$90K$130K$50K$40K$70K
Income before tax-$-5.1M-$-640K-$-260K$70K$200K
Income tax expense$0.00$20K-$-20K-$-10K$10K
Net income-$-5.1M-$-660K-$-240K$80K$190K
Weighted average shares outstanding$16M$12.7M$14.5M$14.5M$14.5M
Weighted average diluted shares outstanding$16M$12.7M$14.5M$14.5M$14.5M
Balance sheet
20252024202320222021
Cash and short-term investments$2.93M$6.16M$230K$70K$140K
Net receivables$300K$360K$230K$480K$770K
Inventory$50K$120K$50K$150K$100K
Total current assets$4.09M$6.68M$530K$720K$1.02M
Property, plant and equipment, net$40K$50K$220K$220K$300K
Goodwill and intangible assets$4.37M$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$5.01M$50K$1.09M$680K$310K
Total assets$9.1M$6.72M$1.62M$1.4M$1.33M
Accounts payable$70K$10K$20K$10K$20K
Short-term debt$140K$250K$50K$50K$60K
Deferred revenue$140K$120K$30K$130K$0.00
Total current liabilities$460K$540K$1.21M$680K$140K
Long-term debt$0.00$0.00$100K$170K$240K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$510K$0.00$110K$170K$240K
Capital lease obligations$0.00$0.00$100K$170K$240K
Total liabilities$970K$540K$1.32M$850K$380K
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-5.62M-$-520K$140K$380K$700K
Accumulated other comprehensive income (loss)$40K$40K$50K$60K$130K
Total equity$8.13M$6.18M$310K$560K$950K
Total investments$1.44M$0.00$0.00$0.00$0.00
Total debt$140K$250K$160K$220K$300K
Net debt-$-1.35M-$-5.91M-$-70K$150K$160K
Cash flow statement
20252024202320222021
Net income-$-5.1M-$-660K-$-240K$80K$190K
Depreciation and amortization$10K$70K$60K$50K$70K
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital-$-1.15M-$-230K$110K-$-270K-$-190K
Accounts receivable-$-20K-$-170K$210K-$-280K$110K
Inventory$70K-$-70K$30K-$-60K$10K
Accounts payable$60K-$-10K$10K-$-10K-$-10K
Net cash provided by operating activities-$-3.24M-$-780K-$-60K-$-120K$80K
Investments in property, plant and equipment-$0.00-$0.00$0.00$0.00$0.00
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-1.35M-$0.00$0.00$0.00$0.00
Common stock issued$170K$7.8M$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00-$-400K$0.00
Net cash used for financing activities-$-80K$6.71M$220K$80K-$-70K
Net change in cash-$-4.67M$5.93M$160K-$-60K$140K
Cash at end of period$1.49M$6.16M$230K$70K$140K
Operating cash flow-$-3.24M-$-780K-$-60K-$-120K$80K
Capital expenditure-$0.00-$0.00-$0.00$0.00$0.00
Free cash flow-$-3.24M-$-780K-$-60K-$-120K$80K
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About iTonic Holdings Ltd.

        iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size. Key among its offerings is FTTPS, a sophisticated treatment planning system engineered for diverse malignant tumors. This system excels at defining the target volume, determining the prescribed dose, establishing safety margins for organs at risk, and formulating a precise dose distribution plan essential for brachytherapy patients. Founded in Beijing, China, in 1998, the company operated as Pheton Holdings Ltd. until its rebranding to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. functions as a subsidiary of ZJW (BVI) LTD.

        CEO
        Jianfei Zhang
        Employees
        7
        Beta
        2.71

        Explore

        Frequently asked questions

        What is the intrinsic value of iTonic Holdings Ltd. (ITOC)?

        InvestorsCraft does not currently publish an intrinsic value for ITOC. How the IC value is calculated.

        Is ITOC undervalued?

        InvestorsCraft does not publish an undervaluation signal for ITOC at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.